// App-Quantinova.ai

Abstract 11095 : Three Year After Acute Coronary Syndrome, 6/10 of the Patients Are Treated in Accordance with International Guidelines in Middle East and North Africa: The Touraco Study

Researchers

Presenter

  • Mohamed Shoby

Principal Investigators

  • Mohammed Arafah

  • Mohamed Alsayed

  • Jassim M Al suwaidi

  • Fahad Baslaib

  • Viraj Rajadhyaksha

  • Djamaleddine Nibouche

  • Ragy Hany

  • Adel Rhouati

  • Nooshin Bazargani

  • Ramez Guindy

Medical Centers

  • Ain Shams Unversity, Cairo, Egypt

  • Egyptian National Cancer Institute, Cairo, Egypt

  • Dubai Hosp, Dubai, United Arab Emirates

  • Cardiology dept, Rashid Hosp, Dubai, United Arab Emirates

  • Hamad Med Corp, Doha, Qatar

  • King Saud University, Riyadh, Saudi Arabia

  • AstraZeneca, Royston, United Kingdom

  • CHU Hussein-Dey, Algiers, Algeria

  • CHU Benbadis, Constantine, Algeria

  • International Cardiac Center, Alexandria, Egypt

  • Astra Zeneca Gulf, Dubai, , United Arab Emirates

Locations

  • Egypt

  • United Arab Emirates

  • Qatar

  • Saudi Arabia

  • United Kingdom

  • Algeria

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Acute Coronary Syndromes

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

  • Multinational

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved